Antiglaucoma compositions and methods

Details Antiglaucoma compositions and methods Antiglaucoma compositions and methods

1985-11-05

1990-03-06

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 3, 514 4, 514 5, 514 6, 514 7, 514 9, 514 10, 514 11, 514 12, 514 13, 514 14, 514 15, 514 17, 514 18, 514 19, 514 20, A61K 3700, A61K 3726, A61K 3714, A61K 3716

Patent

active

049066137

ABSTRACT:
The present invention relates to ophthalmological pharmaceutical compositions comprising a renin inhibitor and to methods for using said composition in the treatment of glaucoma.

REFERENCES:
patent: 3985875 (1976-10-01), Hayaski et al.
patent: 4185096 (1980-01-01), Castro et al.
patent: 4269827 (1981-05-01), Burton et al.
patent: 4384994 (1983-05-01), Veber et al.
patent: 4424207 (1984-01-01), Szelke et al.
patent: 4455303 (1984-01-01), Burton
patent: 4470971 (1984-09-01), Boger et al.
patent: 4477440 (1984-10-01), Boger et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4478826 (1984-10-01), Veber et al.
patent: 4478827 (1984-10-01), Haber et al.
patent: 4479941 (1984-10-01), Veber et al.
patent: 4481192 (1984-11-01), Cazaubon et al.
patent: 4485099 (1984-11-01), Boger et al.
patent: 4510085 (1985-04-01), Hansen, Jr. et al.
patent: 4514332 (1985-04-01), Hansen, Jr. et al.
patent: 4574127 (1986-03-01), Baldwin et al.
patent: 4602093 (1986-07-01), Baldwin et al.
patent: 4749698 (1988-06-01), Neiss et al.
Ionitesu, Oftalmologia vol. 26, No. 2, (1982) pp. 137-138.
Hypertension 6 (Suppl I): I-111, 1984.
Science 175: 656, 1972.
J. Pharm. Exp. Ther. 203: 485, 1977.
Hypertension 4 (Suppl II): II-59, 1982.
Biochem. J. 205: 43, 1982.
Biochem. Biophys. Res. Commun. 118(3): 929, 1984.
Biochemistry 12: 3877, 1973.
Biochemistry 14: 3892, 1975.
Nature 303: 81, 1983.
Nature 299: 555, 1982.
Peptides: Structure and Function, ed. V. J. Hruby, Rockford, Illinois, Pierce Chemical Co., 1984.
Proc. Natl. Acad. Sci. U.S.A. 81: 48, 1984.
Biochem. Biophys. Res. Commun. 100: (1) 177,1981.
J. Clin. Endocrinol. 27: 699, 1967.
Biochem. Pharmacol. 20: 914, 1971.
Proc. Soc. Exp. Biol. Med. 155: 468, 1977.
Am. J. Physiol. 234(6): E 593, 1978.
Biochemistry 19: 2616, 1980.
J. Chem. Soc. Chem. Commun: 109, 1985.
Kokubu et al., Hypertension: 7(3): 837, (1985).
Luly et al., Pharmacologist 27(3): 260, 1985.
Biochem. Biophys. Res. Commun. 54: 1356, 1973.
R. R. Luther et al., Renin Inhibitors: Specific Modulators of the Renin-Angiotensin System, Arzneim-Forsch./Drug Res. 39 (1), Nr. 1 (1989), pp. 1-5.
Miguel A. Ondetti et al., Inhibition of the Renin-Angiotensin System, a New Approach to the Therapy of Hypertension, Journal of Medicinal Chemistry, vol. 24, No. 4, 4/81, pp. 355-361.

Affiliated with

Also associated with

Rating

Antiglaucoma compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiglaucoma compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiglaucoma compositions and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-47509